 LONDON and RALEIGH, N.C., Feb. 17, 2022 GLOBE NEWSWIRE -- Verona Pharma plc Nasdaq: VRNA Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended December 31, 2021 on Thursday, March 3, 2022 and host an investment community conference call at 9:00 a.m. EST 2:00 p.m. GMT to discuss these financial results and provide a corporate update. 